PDCI has now published its information sharing webpage which aggregates submissions made by individuals and organizations in response to Health Canada’s Consultation on Proposed Amendments to the Patented Medicines Regulations.
The submissions have been provided by individuals & organizations on a completely voluntary basis. PDCI is continuing to collect stakeholder submissions to include in this repository. All submissions are welcomed.
If you or your organization responded to Health Canada’s Consultation on Proposed Amendments to the Patented Medicines Regulations and are interested to share your response with the public and stakeholder community please contact PDCI’s Managing Director, Kaitlyn Proulx at Kaitlyn.Proulx@pdci.ca or (613) 742-8225 ext. 33.